Amprius Technologies Inc AMPX 深 滬
等待開盤 01-13 09:30:00 美东时间
10.125
+0.645
+6.80%
華盛通- 最 高10.2494
- 今 開9.76
- 成交量 398.08万股
- 最 低 9.60
- 昨 收 9.48
- 總市值 12.66亿
- 52周最高 16.03
- 市盈率 靜 --
- 換手率 3.18%
- 52周最低 1.70
- 委 比 -22.87%
- 總股本 1.25亿
- 歷史最高 26.01
- 量 比 2.53
- 振 幅 6.85%
- 歷史最低 0.6132
- 每 手 1
- 風險率 3.82%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Oppenheimer’s best small and mid-cap ideas for 2026
Oppenheimer Research released a list of its best ideas for small-caps and mid-caps in the new year. Analysts said that, absent the traditional warning signs that have historically preceded market down...
01-07 00:59
美股周涨跌榜 | 奥麦罗制药周涨近64%！关键药物获FDA批准；矿业股HYMC周涨逾52%
奥麦罗制药周涨近64%！关键药物获FDA批准；矿业股HYMC周涨逾52%，此前宣布高品位银钻探结果；德纳维制药周涨近42%，获制药巨头赛诺菲安万特收购>>
2025-12-27 09:57
Amprius Technologies Appoints President Tom Stepien As CEO, Effective January 1, 2026, Succeeding Dr. Kang Sun
Amprius President Tom Stepien appointed Chief Executive Officer by Board of Directors, effective January 1, 2026Dr. Kang Sun to retire at the end of 2025 and will continue serving on the Amprius Board while acting as an
2025-12-22 21:37
Peering Into Amprius Technologies Inc's Recent Short Interest
Amprius Technologies Inc's (NYSE:AMPX) short interest as a percent of float has...
2025-12-19 23:00
Shares of electrical equipment companies are trading lower amid overall market weakness.
Shares of electrical equipment companies are trading lower amid overall market ...
2025-12-13 04:54
KULR Technology Group Reports Third Quarter 2025 Financial Results
KULR Technology Group reported third-quarter 2025 results with revenue up 116% to $6.88M, driven by product sales growth. Despite a decrease in gross margin to 9%, the company strengthened its balance sheet with $24.54M in cash and accounts receivable. Higher SG&A and R&D expenses led to an operating loss of $8.74M and net loss of $6.97M. Key highlights include partnerships with Amprius and Molicel for KULR ONE Air batteries, a 3.3 MW Bitcoin min...
2025-11-18 21:15
美股大行评级 | 潜在涨幅1307.13%！HC Wainwright & Co.：Adicet Bio获机构升目标价至9美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Adicet Bio"买入"评级，目标价从4美元升至9美元；Citizens: 维持Rapport Therapeutics"跑赢大市"评级，目标价从77美元升至80美元
2025-11-10 17:17
美股大行评级 | 潜在涨幅1307.13%！HC Wainwright & Co.：Adicet Bio获机构升目标价至9美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Adicet Bio"买入"评级，目标价从4美元升至9美元；Citizens: 维持Rapport Therapeutics"跑赢大市"评级，目标价从77美元升至80美元
2025-11-10 10:22
Amprius Technologies shares are trading higher after the company reported better-than-expected Q3 financial results.
Amprius Technologies shares are trading higher after the company reported bette...
2025-11-07 05:51
美股盘后 | Amprius Technologies, Inc. Common Stock涨11.01%
Amprius Technologies第三季度收入1670万美元，每股亏损0.06美元，符合分析师预期。作为高能量密度锂离子电池技术开发商，公司虽仍处亏损状态，但收入表现反映其在该领域的持续投入。
2025-11-07 05:44
